Vista Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
2,968
+336
+13% +$39.3K 0.03% 112
2026
Q1
$317K Buy
+2,632
New +$304K 0.03% 110
2024
Q1
Sell
-2,667
Closed -$291K 98
2023
Q4
$291K Buy
+2,667
New +$277K 0.04% 68
2023
Q3
Sell
-1,758
Closed -$203K 83
2023
Q2
$203K Buy
+1,758
New +$200K 0.03% 88
2020
Q1
Sell
-2,489
Closed -$216K 59
2019
Q4
$216K Sell
2,489
-157
-6% -$12.9K 0.04% 62
2019
Q3
$213K Buy
+2,646
New +$212K 0.04% 60

Other funds holding MRK

Vista Capital Partners's MRK Position: Q2 2026 in Review

Vista Capital Partners increased its Merck (MRK) stake by 13% in Q2 2026, buying an estimated $39.3K and bringing the position to 2,968 shares worth $381K. The position accounts for 0.03% of the portfolio, ranked #112.

Vista Capital Partners first reported a position in MRK in Q3 2019 and has held it in 6 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Vista Capital Partners held 2,968 shares of Merck worth $381K as of Q2 2026.
  • Vista Capital Partners bought 336 Merck shares in Q2 2026, an estimated $39.3K.
  • Merck made up 0.03% of Vista Capital Partners's portfolio in Q2 2026, its #112 holding.
  • Vista Capital Partners first reported a position in Merck in Q3 2019 and has held it in 6 quarters since.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vista Capital Partners's 13F filing for Q2 2026, filed 24 Jul 2026.